{"Abstract": [0], "Recent": [1], "advances": [2], "in": [3], "neoantigen": [4], "research": [5], "have": [6, 88], "accelerated": [7], "the": [8, 93, 106, 143, 153, 164, 172], "development": [9, 95, 134], "and": [10, 22, 55, 66, 77, 83, 99, 109, 119, 128, 150, 166, 170, 190], "regulatory": [11], "approval": [12], "of": [13, 41, 85, 96, 135, 155, 168, 175], "tumor": [14, 36, 125], "immunotherapies,": [15, 118], "including": [16], "cancer": [17, 117, 136], "vaccines,": [18], "adoptive": [19], "cell": [20], "therapy": [21], "antibody-based": [23], "therapies,": [24], "especially": [25], "for": [26, 115, 124], "solid": [27], "tumors.": [28], "Neoantigens": [29, 61], "are": [30, 62], "newly": [31], "formed": [32], "antigens": [33], "generated": [34], "by": [35, 92, 141, 151], "cells": [37], "as": [38, 46, 64, 121], "a": [39], "result": [40], "various": [42], "tumor-specific": [43, 86, 110], "alterations,": [44], "such": [45], "genomic": [47], "mutation,": [48], "dysregulated": [49], "RNA": [50], "splicing,": [51], "disordered": [52], "post-translational": [53], "modification,": [54], "integrated": [56], "viral": [57], "open": [58], "reading": [59], "frames.": [60], "recognized": [63], "non-self": [65], "trigger": [67], "an": [68, 161], "immune": [69, 129, 148], "response": [70, 149], "that": [71], "is": [72], "not": [73], "subject": [74], "to": [75, 103], "central": [76], "peripheral": [78], "tolerance.": [79], "The": [80, 133], "quick": [81], "identification": [82, 165], "prediction": [84], "neoantigens": [87, 111, 169], "been": [89], "made": [90], "possible": [91], "advanced": [94], "next-generation": [97], "sequencing": [98], "bioinformatic": [100], "technologies.": [101], "Compared": [102], "tumor-associated": [104], "antigens,": [105], "highly": [107], "immunogenic": [108], "provide": [112], "emerging": [113], "targets": [114], "personalized": [116], "serve": [120], "prospective": [122, 176], "predictors": [123], "survival": [126], "prognosis": [127], "checkpoint": [130], "blockade": [131], "responses.": [132], "therapies": [137], "will": [138], "be": [139], "aided": [140], "understanding": [142], "mechanism": [144], "underlying": [145], "neoantigen-induced": [146], "anti-tumor": [147], "streamlining": [152], "process": [154], "neoantigen-based": [156], "immunotherapies.": [157], "This": [158], "review": [159], "provides": [160], "overview": [162], "on": [163, 180], "characterization": [167], "outlines": [171], "clinical": [173, 191], "applications": [174], "immunotherapeutic": [177], "strategies": [178], "based": [179], "neoantigens.": [181], "We": [182], "also": [183], "explore": [184], "their": [185], "current": [186], "status,": [187], "inherent": [188], "challenges,": [189], "translation": [192], "potential.": [193]}